Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SKB discloses NK3 antagonists in patent literature

April 19, 1996

Nikken Chemicals describes antiallergy agents

April 19, 1996

CMI-568, dual PAF antagonist and 5-LO inhibitor from CytoMed

April 19, 1996

Abbott claims new 5-LO inhibitors

April 19, 1996

Two novel series of LTB4 antagonists from Boehringer Ingelheim

April 19, 1996

Leukotriene D4 antagonists reported by Leo Denmark

April 19, 1996

Sanofi Winthrop claims elastase inhibitors

April 12, 1996

Zafirlukast approval recommended

April 12, 1996

New antiasthma drugs from the SmithKline Beecham Laboratory

April 12, 1996

rPAF-AH moves to phase I

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.